Newsletter
Biotech startup Utopia Therapeutics has raised $1.5 million in seed funding from Water Tank.
The deets: Utopia Therapeutics develops disruptive immunotherapies that address the root causes of chronic illnesses. It aims to deliver vaccines for obesity and related metabolic diseases using scientific approaches.
The proceeds from this round will accelerate the preclinical development of UT009, aimed at treating obesity.
Why it matters: India currently has no approved obesity vaccines. However, Utopia Therapeutics’ candidate could mark a breakthrough if successful. The vaccine is still in the preclinical stage, with encouraging early results in animal studies.
What’s Next: the company aims to file an Investigational New Drug (IND) application by late 2025. If initial trials go well, Utopia plans to move through regulatory safety and efficacy phases, with a goal of reaching the market in 5 to 7 years.
